Listen: Pharma blockbusters, pandemic policy, & legal chicanery
Is the next Lipitor on the way? When is a pandemic over-over? And what’s a Texas two-step?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. STAT Washington correspondent Rachel Cohrs joins us to explain the looming end of Covid-19’s status as a federal emergency and what that does and doesn’t mean for public health. We also dig into the most interesting stories from a busy week of pharmaceutical earnings and discuss a legal setback for Johnson & Johnson.
Read Original Article: Listen: Pharma blockbusters, pandemic policy, & legal chicanery »
